Clinical Trials and Research

Balt’s Squid Liquid Embolic Receives FDA Approval for Adjunctive Treatment for Patients with Chronic Subdural Hematomas

The approval comes following the results from The Squid Trial for the Embolisation of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma study...

SMART and NUS Pioneer Neural Blueprint for Human-like Intelligence in Soft Robots

A newly developed AI control system using neuron-inspired learning enables soft robotic arms to learn a broad set of motions once and adapt instantly to changing conditions without retraining...

Trace Biosciences Announces FDA IND Clearance for First Nerve-Specific Imaging Agent

The IND clearance enables Trace to initiate first-in-human clinical studies evaluating the safety and intraoperative performance of LGW16-03 in surgical settings...

Laborie Acquires the JADA System for Rapid Postpartum Haemorrhage Control

The JADA System for treatment of abnormal postpartum uterine bleeding, and the team behind the product, join Laborie, strengthening the company's commitment to improving maternal health...

Redefining Cardiopulmonary Trials with Functional Imaging Biomarkers

Polarean’s Xenon MRI platform is opening a new window into the pulmonary microvasculature, long considered a “silent zone” in cardiopulmonary disease and reshaping how pharma sponsors evaluate therapeutic response...

Pusan National University Researchers Develop Light-Activated Tissue Adhesive Patch for Rapid, Watertight Neurosurgical Sealing

Researchers develop an innovative dural patch that achieves rapid, watertight sealing of dural tears, boasting high biocompatibility...

Siemens Healthineers Receives FDA Clearance for 70cm Magnetom Flow. 1.5 Tesla Magnetic Resonance Platform

Artificial intelligence simplifies patient workflow, improves image quality, and accelerates exams...

Spectrumedics Announces CE Mark Approval for Coronary Intravascular Lithotripsy System

This important regulatory milestone further strengthens Spectrumedics' global expansion strategy...

NTPC Signs MoA with Gujarat Cancer & Research Institute for Upgradation of Radiotherapy Services

This initiative reaffirms NTPC’s commitment to inclusive development and its continued focus on strengthening critical healthcare infrastructure through meaningful CSR interventions...

Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH CTC enumeration

203 patients were randomised to receive either endocrine monotherapy or combination therapy consisting of a doublet (endocrine therapy plus a CDK4/6 inhibitor) ...